Govorestat is a central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) being developed for the treatment of multiple rare diseases including Classic Galactosemia, Sorbitol ...
DURHAM, N.C., Nov. 22, 2024 (GLOBE NEWSWIRE) -- SECU Foundation continues its support for the non-profit TROSA (Triangle Residential Options for Substance Abusers, Inc.) with a $1 million capital ...